Status:
COMPLETED
Neurologic Manifestations of COVID 19 in Children
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
University of Utah
Johns Hopkins University
Conditions:
COVID
Neurologic Manifestations
Eligibility:
All Genders
Up to 17 years
Brief Summary
The purpose of this study is to perform a secondary analysis of pre-existing de-identified limited datasets obtained from sites participating in Tier 1 (STUDY20040154: Neurologic Manifestations of COV...
Detailed Description
Early reports of COVID-19 indicate that adults experience a variety of neurological symptoms and diagnoses in approximately 36% of patients, including headaches, seizures, coma, encephalitis, and cere...
Eligibility Criteria
Inclusion
- Infants, children, and young adults age \< 18 years
- Admitted to the hospital with confirmed or presumed COVID-19 infection (includes admissions to emergency, ward, intensive care etc.)
Exclusion
- none
Key Trial Info
Start Date :
April 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
3568 Patients enrolled
Trial Details
Trial ID
NCT04379089
Start Date
April 29 2020
End Date
December 31 2022
Last Update
January 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15224